Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...

These data indicate that either alternative vaccine strategies or alternative strategies to protect these patients from pneumococcal disease are required,’ said Michael Chen-Xu, MD.

Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Anti-Neutrophil Cytoplasmic Antibody - Associated Vasculitis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ...

SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally ...

Pivotal trial demonstrated avacopan’s statistical superiority in sustaining remission at 52 weeks over the glucocorticoid-containing standard-of-care therapy MOUNTAIN VIEW, Calif., June 03, 2020 ...

Please provide your email address to receive an email when new articles are posted on . “Today is a momentous day in the history of ChemoCentryx; the culmination of decades of effort aimed at offering ...

Cigarette smoking was associated with ANCA-associated vasculitis, particularly myeloperoxidase ANCA-positive vasculitis, according to data published in JAMA Internal Medicine. “We have an incomplete ...

A population-based study of Swedish adults found that ANCA-associated vasculitis is more prevalent among men than women. Despite a stable incidence of ANCA-associated vasculitis in southern Sweden, ...

Bronchiectasis is a common pulmonary feature among a subset of patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis, French researchers reported. The ANCA-associated ...

Small-vessel vasculitic syndromes such as Wegener granulomatosis and microscopic polyangiitis, which are associated with circulating antineutrophil cytoplasmic autoantibodies, are an important cause ...

Wegener's granulomatosis, microscopic polyangiitis (MPA), Churg–Strauss syndrome, and primary pauci-immune crescentic glomerulonephritis are associated with circulating anti-neutrophil cytoplasmic ...

"ANCA Vasculitis Pipeline 2025"DelveInsight's,“ANCA Vasculitis - Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline ...